Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update

MELBOURNE, Australia, Jan. 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at the 41st Annual J.P. Morgan Healthcare Conference (9 – 12 January) in San Francisco. As part of the Company's presentation (available to view...

Click to view original post